Profile
Full Name
Arrowhead Pharmaceuticals, Inc.Ticker Symbol
ARWRExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
December 16, 1993Indexes
Not includedWebsite
http://arrowheadpharma.comEmployees
609Key Details
Price
$12.53
Market Cap
$1.58B(Small cap)
Last Dividend
-
TTM Dividend Yield
-
Annual Revenue
$3.55M(-98.52% YoY)
Annual EPS
-$5.00(-160.42% YoY)
PE Ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Arrowhead Pharmaceuticals doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Feb 14, 25 B. Riley Securities
BuyFeb 12, 25 HC Wainwright & Co.
BuyFeb 11, 25 RBC Capital
OutperformFeb 11, 25 Chardan Capital
BuyJan 23, 25 HC Wainwright & Co.
BuyJan 22, 25 HC Wainwright & Co.
BuyDec 20, 24 HC Wainwright & Co.
BuyDec 12, 24 Chardan Capital
BuyDec 3, 24 HC Wainwright & Co.
BuyNov 29, 24 Bernstein
Market PerformInstitutional Ownership
- What is the ticker symbol for Arrowhead Pharmaceuticals?
- Does Arrowhead Pharmaceuticals pay dividends?
- What sector is Arrowhead Pharmaceuticals in?
- What industry is Arrowhead Pharmaceuticals in?
- What country is Arrowhead Pharmaceuticals based in?
- When did Arrowhead Pharmaceuticals go public?
- Is Arrowhead Pharmaceuticals in the S&P 500?
- Is Arrowhead Pharmaceuticals in the NASDAQ 100?
- Is Arrowhead Pharmaceuticals in the Dow Jones?
- When was Arrowhead Pharmaceuticals's last earnings report?
- When does Arrowhead Pharmaceuticals report earnings?
- Should I buy Arrowhead Pharmaceuticals stock now?
What is the ticker symbol for Arrowhead Pharmaceuticals?
The ticker symbol for Arrowhead Pharmaceuticals is NASDAQ:ARWR
Does Arrowhead Pharmaceuticals pay dividends?
No, Arrowhead Pharmaceuticals does not pay dividends
What sector is Arrowhead Pharmaceuticals in?
Arrowhead Pharmaceuticals is in the Healthcare sector
What industry is Arrowhead Pharmaceuticals in?
Arrowhead Pharmaceuticals is in the Biotechnology industry
What country is Arrowhead Pharmaceuticals based in?
Arrowhead Pharmaceuticals is headquartered in United States
When did Arrowhead Pharmaceuticals go public?
Arrowhead Pharmaceuticals's initial public offering (IPO) was on December 16, 1993
Is Arrowhead Pharmaceuticals in the S&P 500?
No, Arrowhead Pharmaceuticals is not included in the S&P 500 index
Is Arrowhead Pharmaceuticals in the NASDAQ 100?
No, Arrowhead Pharmaceuticals is not included in the NASDAQ 100 index
Is Arrowhead Pharmaceuticals in the Dow Jones?
No, Arrowhead Pharmaceuticals is not included in the Dow Jones index
When was Arrowhead Pharmaceuticals's last earnings report?
Arrowhead Pharmaceuticals's most recent earnings report was on Feb 10, 2025
When does Arrowhead Pharmaceuticals report earnings?
The next expected earnings date for Arrowhead Pharmaceuticals is May 9, 2025
Should I buy Arrowhead Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions